Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT06387875
Recruiting Observational

Cohort in Qianwan New District, Ningbo

NCT06387875 · tracked via the Priya Life Science China tracker
Sponsor
RenJi Hospital
Phase
Observational
Started
2023-11-01
Last updated
2024-04-29

Condition(s) studied

Cardiovascular DiseasesStrokeNon-Communicable Chronic Diseases

Study summary

Our objective is to carry out research on prevention and control of noncommunicable chronic diseases, and establish a risk prediction mechanism for chronic diseases to promote early detection, early diagnosis and early treatment of chronic diseases in natural population in Qianwan District of Ningbo, significantly reduce medical costs and extend population life span.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * 1\) Local permanent residents aged 18 and above (including residents with household registration, or residents without household registration but with a permanent job); * 2\) No serious physical disability, can communicate normally; * 3\) Participate voluntarily and sign informed consent. Exclusion Criteria: * 1\) Temporary resident and floating population; * 2\) There are serious health conditions unable to participate in the survey; * 3\) Those who are unwilling to accept the follow-up inspection of the project.

Primary outcome measure(s)

  • death — 4 years
    Mortality of all-cause disease were calculated by age, gender and area compared by different health management mode.
  • incidence of cardio-cerebrovascular diseases — 4 years
    Incidence of Cardiovascular and Cerebrovascular diseases were calculated by age, gender and area compared by different health management mode.
  • incidence of other non-communicable chronic diseases — 4 years
    Incidence of other non-communicable chronic diseases were calculated by age, gender and area compared by different health management mode.

Trial sites (1)

FacilityCityRegionStatus
Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University Shanghai China Recruiting

More RenJi Hospital trials in China

Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma Recruiting
Effectiveness of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure Recruiting
Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC Starting soon
CD70-targeted immunoPET Imaging of Kidney Cancer Recruiting
CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer Recruiting

Other trials for the same condition

Study on the Incremental Predictive Value of Early Resting-State EEG Phenotypes for Functional Prognosis and Risk Stratification in Acute Ischemic Stroke Starting soon
Study on the Correlation Mechanism and Application of Genetic Susceptibility, Hemoglobin Adaptation Changes, and Extubation Success Rate in Stroke Patients With Tracheotomy at Different Altitudes Recruiting
Art Therapy and Its Effect on Motor Function Rehabilitation in the Subacute Phase of Stroke Recovery Recruiting
Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting Recruiting
Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06387875 on ClinicalTrials.gov ↗ ← All trials in China